Literature DB >> 27218665

miR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1).

Shuxian Hu1, Mingzhi Zhang1, Fen Sun1, Lipeng Ren1, Xin He1, Jinlian Hua1, Sha Peng1.   

Abstract

OBJECTIVES: miR-375 is one of the highly expressed microRNAs (miRNAs) found in pancreatic islets of both humans and mice. In this study, we investigated functions of miRNA miR-375 in porcine pancreatic stem cells (PSC).
MATERIALS AND METHODS: We transfected mimic and inhibitor of miR-375 in PSCs to measure functional roles of the microRNA and its effects on cell cycle proliferation and cell differentiation were determined. Luciferase assays were also performed to reveal the target gene of miR-375.
RESULTS: Overexpression of miR-375 suppressed proliferation, promoted apoptosis and inhibited differentiation into islet-like cells. PDK1 was identified as being a target of miR-375. Furthermore, we found that overexpression of miR-375 inhibited activation of the PDK1-AKT signalling pathway.
CONCLUSION: miR-375 directly targeted PDK1 in porcine PSCs, suppressing cell proliferation and differentiation into islet-like cells.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27218665      PMCID: PMC6495784          DOI: 10.1111/cpr.12263

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  40 in total

1.  Building better beta cells.

Authors:  Edouard G Stanley; Andrew G Elefanty
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

Review 2.  MiR-375, a microRNA related to diabetes.

Authors:  Xueling Li
Journal:  Gene       Date:  2013-10-10       Impact factor: 3.688

3.  Global estimates of diabetes prevalence for 2013 and projections for 2035.

Authors:  L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw
Journal:  Diabetes Res Clin Pract       Date:  2013-12-01       Impact factor: 5.602

Review 4.  MicroRNAs as new player in rheumatoid arthritis.

Authors:  Isabelle Duroux-Richard; Jessy Presumey; Gabriel Courties; Steffen Gay; Jan Gordeladze; Christian Jorgensen; Diego Kyburz; Florence Apparailly
Journal:  Joint Bone Spine       Date:  2011-01       Impact factor: 4.929

5.  Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques.

Authors:  S A Rogers; F Chen; M R Talcott; C Faulkner; J M Thomas; M Thevis; M R Hammerman
Journal:  Xenotransplantation       Date:  2007-11       Impact factor: 3.907

6.  miR-375 maintains normal pancreatic alpha- and beta-cell mass.

Authors:  Matthew N Poy; Jean Hausser; Mirko Trajkovski; Matthias Braun; Stephan Collins; Patrik Rorsman; Mihaela Zavolan; Markus Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

7.  Expression levels of microRNA-375 in pancreatic cancer.

Authors:  Shiduo Song; Jian Zhou; Songbing He; Dongming Zhu; Zixiang Zhang; Hua Zhao; Yi Wang; Dechun Li
Journal:  Biomed Rep       Date:  2013-03-27

8.  Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes.

Authors:  Jia Cheng; Lingyan Wang; Leiting Xu; Hongwei Wang; Panpan Liu; Shizhong Bu; Meng Ye; Lina Zhang; Qinwen Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2013-04-18       Impact factor: 2.447

9.  GSK3 inhibitor-BIO regulates proliferation of immortalized pancreatic mesenchymal stem cells (iPMSCs).

Authors:  Hui Cao; Yuankui Chu; Xiao Lv; Pubin Qiu; Chao Liu; Huiru Zhang; Dan Li; Sha Peng; Zhongying Dou; Jinlian Hua
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.

Authors:  Martijn van de Bunt; Kyle J Gaulton; Leopold Parts; Ignasi Moran; Paul R Johnson; Cecilia M Lindgren; Jorge Ferrer; Anna L Gloyn; Mark I McCarthy
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more
  6 in total

1.  MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Wenfeng Xian; Liuyu Wang; Xunmeng Ding
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

2.  miR-18a counteracts AKT and ERK activation to inhibit the proliferation of pancreatic progenitor cells.

Authors:  Xuyan Li; Zhenwu Zhang; Yunchao Li; Yicheng Zhao; Wenjun Zhai; Lin Yang; Delin Kong; Chunyan Wu; Zhenbao Chen; Chun-Bo Teng
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

Review 3.  Molecular biomarkers in diabetes mellitus (DM).

Authors:  Seyed Mohsen Aghaei Zarch; Masoud Dehghan Tezerjani; Mehrdad Talebi; Mohammad Yahya Vahidi Mehrjardi
Journal:  Med J Islam Repub Iran       Date:  2020-04-01

4.  MiR-485-3p modulates neural stem cell differentiation and proliferation via regulating TRIP6 expression.

Authors:  Juxian Gu; Rusheng Shao; Meng Li; Qiuyue Yan; Hongwei Hu
Journal:  J Cell Mol Med       Date:  2019-11-15       Impact factor: 5.310

Review 5.  The Implications of ncRNAs in the Development of Human Diseases.

Authors:  Elena López-Jiménez; Eduardo Andrés-León
Journal:  Noncoding RNA       Date:  2021-02-24

6.  Resveratrol controlled the fate of porcine pancreatic stem cells through the Wnt/β-catenin signaling pathway mediated by Sirt1.

Authors:  Shuanshuan Xu; Fen Sun; Lipeng Ren; Hong Yang; Na Tian; Sha Peng
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.